Form 4 for MRNA Moderna
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-08 · accession 0001127602-24-026997 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | 2024-11-08 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +523 | 1.44M | +0.0% | — |
| D | 2024-11-12 | 2024-11-11 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $46.10 | -277 | 1.44M | -0.0% | -$12.8K |
| D | 2024-11-12 | 2024-11-08 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -523 | 523 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | M | A | 523 | — | 1,443,525 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-11-11 | S | D | 277 | $46.10 | 1,443,248 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-11-08 | M | D | 523 | $0.00 | 523 | D | — · — to — | 523 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |